Immunokine®
Immunokine® is an inorganic immunomodulating compound manufactured in an original, patented process. Its pharmacological action comprises of the promotion of the immune functions through the activation of macrophages.
Immunokine® promotes tissue repair and -regeneration from damages caused by radiation-therapy.
Indication
Immunomodulator to be used as adjunct in the treatment of cancer to relieve post-radiation-therapy syndromes.
As adjunct therapy together with standard treatment of diabetic foor ulcer under physician's judgement.
Immunokine® is approved and marketed only in Thailand.